-
Modeling immunotherapy of the tumor-immune interaction
-
Modeling immunotherapy of the tumor-immune interaction
Located in
Exposures
/
Kirschner, Panetta, 1998
-
Modeling immunotherapy of the tumor-immune interaction
-
Modeling immunotherapy of the tumor-immune interaction
Located in
Exposures
/
Kirschner, Panetta, 1998
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
Located in
Exposures
/
Lenbury, Ruktamatakul, Amornsamarnkul, 2001
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
Located in
Exposures
/
Lenbury, Ruktamatakul, Amornsamarnkul, 2001
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
Located in
Exposures
/
Lenbury, Ruktamatakul, Amornsamarnkul, 2001
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions (Extended Model)
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
Located in
Exposures
/
Lenbury, Ruktamatakul, Amornsamarnkul, 2001
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions (Basic Model)
-
Modeling insulin kinetics: responses to a single oral glucose administration or ambulatory-fed conditions
Located in
Exposures
/
Lenbury, Ruktamatakul, Amornsamarnkul, 2001
-
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy (Extended Model)
-
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy
Located in
Exposures
/
Rong, Perelson, 2009
-
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy
-
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy
Located in
Exposures
/
Rong, Perelson, 2009
-
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy
-
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy
Located in
Exposures
/
Rong, Perelson, 2009
